Autologous peripheral stem cell transplantation for aggressive hemophagocytic syndrome associated with T-cell lymphoma: case study and review

Am J Hematol. 2002 Jan;69(1):64-6. doi: 10.1002/ajh.10009.

Abstract

Hemophagocytic syndrome (HPS) is a rare clinical presentation infrequently associated with lymphoproliferative disorders. We describe a 29-year-old male with aggressive HPS and T-cell lymphoma managed successfully with high-dose chemotherapy and autologous peripheral stem cell transplantation (APSCT), in remission at 41 months of follow-up. In reviewing the literature, this case illustrates the 2nd longest surviving individual post stem cell transplant for aggressive HPS.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biopsy
  • Hematopoietic Stem Cell Transplantation*
  • Histiocytosis, Non-Langerhans-Cell / complications
  • Histiocytosis, Non-Langerhans-Cell / pathology
  • Histiocytosis, Non-Langerhans-Cell / therapy*
  • Humans
  • Lymph Nodes / pathology
  • Lymphoma, T-Cell / complications*
  • Male
  • Remission Induction
  • Skin / blood supply
  • Skin / pathology
  • Spleen / pathology
  • T-Lymphocytes / pathology
  • Transplantation, Autologous